Literature DB >> 3293569

Glucosphingolipids as sites of action in the chemotherapy of cancer.

N S Radin1, J Inokuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3293569     DOI： 10.1016/0006-2952(88)90271-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  Charged membrane surfaces impede the protein-mediated transfer of glycosphingolipids between phospholipid bilayers.

Authors:  P Mattjus; H M Pike; J G Molotkovsky; R E Brown
Journal:  Biochemistry       Date:  2000-02-08       Impact factor: 3.162

2.  Differential effects of synthetic sphingosine derivatives on melanoma cell motility, growth, adhesion and invasion in vitro.

Authors:  C Helige; J Smolle; R Fink-Puches; R Hofmann-Wellenhof; E Hartmann; T Bär; R R Schmidt; H A Tritthart
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

Review 3.  Gangliosides in T cell development and function of mice.

Authors:  Jin-Ichi Inokuchi; Masakazu Nagafuku
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

4.  Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.

Authors:  H Saito; S Tada; H Ebinuma; S Tsunematsu; T Kagawa; N Kumagai; Y Inagaki; T Watanabe; K Tsuchimoto; T Morizane
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

Review 5.  Killing tumours by ceramide-induced apoptosis: a critique of available drugs.

Authors:  Norman S Radin
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

6.  Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.

Authors:  L S Manning; N S Radin
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

7.  β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model.

Authors:  Ehud Zigmond; Oshrat Tayer-Shifman; Gadi Lalazar; Ami Ben Ya'acov; Sarah Weksler-Zangen; David Shasha; Miriam Sklair-Levy; Lidya Zolotarov; Zvi Shalev; Rony Kalman; Ehud Ziv; Itamar Raz; Yaron Ilan
Journal:  J Inflamm Res       Date:  2014-10-08

Review 8.  Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease.

Authors:  Yaron Ilan
Journal:  Clin Transl Immunology       Date:  2016-01-29

Review 9.  Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.

Authors:  Y Ilan
Journal:  Aliment Pharmacol Ther       Date:  2016-10-24       Impact factor: 8.171

10.  Development of antimetastatic drugs by targeting tumor sialic acids.

Authors:  Da-Yong Lu; Ting-Ren Lu; Hong-Ying Wu
Journal:  Sci Pharm       Date:  2012-06-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.